Article · 20 Aug 2025
Conference abstract
Intellectual property and regulatory challenges of microbiome inventions: Recent trends and solutions
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: In recent years, the use of Microbiome and their metabolites for clinical diagnostics and as therapeutics has gained increased attention as modes of treatment for various disorders. This has led to many start-up companies conducting clinical trials for various chronic diseases; as diverse as IBD and liver diseases. In spite of vast progress in this field, one of the major concerns for researchers is securing the Intellectual property rights (mainly patents) on Microbiome inventions (Bacteria, Viruses, and Fungi) that are categorized as naturally occurring products and therefore come under the Judicial exception of 35 U.S.C 101. In the present talk, I will discuss a few patents which have been successfully granted and are commercialized. Additionally, this talk will also cover the regulatory challenges associated with the use of live microbiome as biotherapeutics with recent trends and solutions.
Keywords
Subjects
Nursing & HealthcareAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Health Care : Current Reviews.
Article · 15 Aug 2025
Pharmacogenomics and the Future of Drug Development: A Current Review
Article · 15 Aug 2025
Artificial Intelligence in Health Care: Current Applications and Future Directions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalHealth Care : Current Reviews
- SubjectNursing & Healthcare
- BylineArticles whose byline prints “Kamala Janiyani”
